InvestorsObserver
×
News Home

Is Amarin Corporation plc (AMRN) a Winner in the Biotechnology Industry?

Monday, September 28, 2020 09:55 AM | InvestorsObserver Analysts

Mentioned in this article

Is Amarin Corporation plc (AMRN) a Winner in the Biotechnology Industry?

The 34 rating InvestorsObserver gives to Amarin Corporation plc (AMRN) stock puts it near the bottom of the Biotechnology industry. In addition to scoring higher than 26 percent of stocks in the Biotechnology industry, AMRN’s 34 overall rating means the stock scores better than 34 percent of all stocks.

Overall Score - 34
AMRN has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on AMRN!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Amarin Corporation plc Stock Today?

Amarin Corporation plc (AMRN) stock is trading at $3.96 as of 9:52 AM on Monday, Sep 28, a gain of $0.15, or 3.93% from the previous closing price of $3.81. The stock has traded between $3.88 and $4.09 so far today. Volume today is light. So far 1,455,076 shares have traded compared to average volume of 11,531,900 shares.

Click Here to get the full Stock Score Report on Amarin Corporation plc (AMRN) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App